| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enveric Biosciences, Inc. (ENVB) has 7 insiders with recent SEC Form 4 filings, including 16 buys and 0 sells. ENVB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 70.4K | $200.5K | - | |
| CFO | 47.4K | $135.1K | - | |
| Dir | 7.9K | $22.5K | - | |
| Dir | 7.9K | $22.5K | - | |
| Dir | 7.9K | $22.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 20, 2016 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 526 | $6.51 | $3,424.26 | +0.4% | |
| Sep 26, 2016 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 183 | $6.51 | $1,191.33 | +0.3% | |
| Sep 2, 2016 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 18,685 | $6.51 | $121,639.35 | +16.5% | |
| Aug 31, 2016 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 1,094 | $6.51 | $7,121.94 | +1.2% | |
| Aug 25, 2016 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 450 | $6.51 | $2,928.50 | +0.5% | |
| Aug 22, 2016 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 1,023 | $6.41 | $6,558.73 | +0.8% | |
| Aug 9, 2016 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 124 | $6.51 | $807.24 | +0.3% | |
| Jul 27, 2016 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 103 | $6.51 | $670.53 | +0.2% | |
| Jul 25, 2016 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 308 | $6.51 | $2,005.08 | +0.7% | |
| Jul 12, 2016 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 200 | $6.51 | $1,302.00 | +0.5% |